<html>
 <head> 
 </head> 
 <body> 
  <text encoding="utf8" id="http://www.chfpatients.com/faq/dhf.htm" title="CHFpatients.com - Heart Failure FAQ - Diastolic Heart Failure"> 
   <h1 class="center"> <span __num="0" __label="true"> Diastolic Heart Failure </span> </h1> 
   <div style="border:6px double #099; margin-right:20%; margin-left:20%"> 
    <p class="note" style="margin:7px 1% 7px 1%; text-align:center"> <span __num="1" __label="true"> The heart's pumping cycle has 2 phases </span> <b> <span __num="2" __label="true"> : </span> </b> <br> <span style="font:x-small Arial,sans-serif; line-height:50%"> </span> <br> <span style="background:transparent; color:#099; font:bold x-small Verdana,Arial,sans-serif"> <span __num="3" __label="true"> Diastole </span> </span> <br> <span style="font-weight:normal"> <span __num="4" __label="true"> (pronounced </span> <b> <span __num="5" __label="true"> : </span> </b> <span __num="6" __label="true"> die ass tuh lee) </span> </span> <br> <span __num="7" __label="true"> the heart muscle relaxes and fills with blood </span> <br> <span style="font:x-small Arial,sans-serif; line-height:50%"> </span> <br> <span style="background:transparent; color:#099; font:bold x-small Verdana,Arial,sans-serif"> <span __num="8" __label="true"> Systole </span> </span> <br> <span style="font-weight:normal"> <span __num="9" __label="true"> (pronounced </span> <b> <span __num="10" __label="true"> : </span> </b> <span __num="11" __label="true"> sis tuh lee) </span> </span> <br> <span __num="12" __label="true"> the heart muscle contracts (squeezes) and pumps blood out into the body </span> </p> 
   </div> 
   <p> <br> <span style="font:bold xx-small Verdana,Arial,sans-serif"> <span __num="13" __label="true"> updated July 5, 2006 </span> </span> <span __num="14" __label="true"> - People think of heart failure as a condition where the heart does not pump out enough blood. That is called systolic heart failure. However, many </span> <a href="http://www.chfpatients.com/glossary.htm#chfer" target="_blank"> <span __num="15" __label="true"> CHFers </span> </a> <span __num="16" __label="true"> have a different kind of heart failure - caused when the heart does not fully relax, so it does not fill properly with blood. This is called diastolic heart failure. This page is about diastolic heart failure or DHF. </span> <br> <span __num="17" __label="true"> In mild DHF, </span> <a href="http://www.chfpatients.com/glossary_2.htm#sob" target="_blank"> <span __num="18" __label="true"> SOB </span> </a> <span __num="19" __label="true"> and fatigue usually only happen during stress or activity. More severe DHF causes many of the same symptoms that systolic heart failure or SHF, causes. </span> <br> <span __num="20" __label="true"> A person with DHF has high pressures in the arteries of their lungs - pulmonary pressure. Their heart's pumping chambers may not be enlarged and their </span> <a href="http://www.chfpatients.com/faq/ef.htm" target="_blank"> <span __num="21" __label="true"> ejection fraction </span> </a> <span __num="22" __label="true"> may be normal, but they still have the same nasty symptoms as a person with SHF. </span> <br> <span class="h"> <span __num="23" __label="true"> In people with diastolic heart failure, </span> <a href="http://www.chfpatients.com/text/toprol-xl_versus_metoprolol.txt" target="_blank"> <span __num="24" __label="true"> Toprol-XL </span> </a> <span __num="25" __label="true"> may be a better beta-blocker choice than Coreg. Too-low blood pressure can be a real problem for DHF patients. Toprol-XL does not lower blood pressure as much as Coreg. </span> </span> </p> 
   <ul> 
    <li> <a href="#causes"> <span __num="26"> What Causes DHF? </span> </a> </li> 
    <li> <a href="#diagnosing"> <span __num="27"> Diagnosing DHF </span> </a> </li> 
    <li> <a href="#prevalence"> <span __num="28"> How Common Is DHF? </span> </a> </li> 
    <li> <a href="#mortality"> <span __num="29"> Mortality </span> </a> </li> 
    <li> <a href="#complications"> <span __num="30"> Complications </span> </a> </li> 
    <li> <a href="#treatment"> <span __num="31"> Treating Diastolic Heart Failure </span> </a> 
     <ul> 
      <li> <a href="#drug_general"> <span __num="32"> Drug Therapy - General Principles </span> </a> </li> 
      <li> <a href="#nebivolol_for_seniors_with_good_EF"> <span __num="33"> New Drug Nebivolol Helps CHF Seniors with Normal EF </span> </a> </li> 
      <li> <a href="#exercise"> <span __num="34"> Drugs and Exercise Tolerance </span> </a> </li> 
      <li> <a href="#inotropes"> <span __num="35"> IV Drugs </span> </a> </li> 
      <li> <a href="#digoxin"> <span __num="36"> Digoxin (Lanoxin, digitalis) </span> </a> </li> 
      <li> <a href="#cad"> <span __num="37"> Coronary Artery Disease </span> </a> </li> 
     </ul> </li> 
    <li> <a href="#q_and_a"> <span __num="38"> Questions and Answers - The Discussion </span> </a> </li> 
    <li> <a href="#source"> <span __num="39"> Source For This Page's Information </span> </a> </li> 
    <li> <a href="http://www.chfpatients.com/text/faq_dhf_references.txt" target="_blank"> <span __num="40"> References </span> </a> </li> 
   </ul> 
   <h2> <span __num="41" __label="true"> Causes of diastolic heart failure </span> <a name="causes"> </a> </h2> 
   <ul> 
    <li> <a href="http://www.chfpatients.com/glossary_2.htm#ischemia" target="_blank"> <span __num="42" __label="true"> Ischemia </span> </a> <span __num="43" __label="true"> - can be caused by </span> <a href="http://www.chfpatients.com/glossary.htm#cad" target="_blank"> <span __num="44" __label="true"> CAD </span> </a> <span __num="45" __label="true"> or by a chronic too-fast heart rate. Ischemia prevents the heart muscle from fully relaxing and increases heart stiffness. Chronic ischemia results in </span> <a href="http://www.chfpatients.com/glossary_2.htm#remodeling" target="_blank"> <span __num="46" __label="true"> remodeling </span> </a> <span __num="47" __label="true"> and DHF </span> </li> 
    <li> <span __num="48" __label="true"> pressure overload caused by chronic high blood pressure or aortic valve problems </span> </li> 
    <li> <span __num="49" __label="true"> infiltrative cardiomyopathies, also called restrictive cardiomyopathy </span> </li> 
    <li> <span __num="50" __label="true"> pericarditis - inflammation of the sac around the outside of the heart </span> </li> 
    <li> <span __num="51" __label="true"> normal aging can cause some DHF </span> 
     <!--abnormalities of cellular calcium handling, increased collagen that hampers relaxation, increased stiffness--> </li> 
    <li> <span __num="52" __label="true"> chemotherapy for diseases like cancer </span> </li> 
    <li> <span __num="53" __label="true"> genetic causes </span> </li> 
   </ul> 
   <h3> <span __num="54" __label="true"> Diagnosing diastolic heart failure </span> <a name="diagnosing"> </a> </h3> 
   <p> <span __num="55" __label="true"> How to always diagnose DHF accurately is uncertain but a correct diagnosis </span> <i> <span __num="56" __label="true"> is </span> </i> <span __num="57" __label="true"> important. Some guidelines propose that 3 requirements be met to make the call </span> <b> <span __num="58" __label="true"> : </span> </b> </p> 
   <ol> 
    <li> <span __num="59" __label="true"> symptoms or signs of </span> <a href="http://www.chfpatients.com/CHFinfo.htm" target="_blank"> <span __num="60" __label="true"> CHF </span> </a> </li> 
    <li> <span __num="61" __label="true"> normal systolic function </span> </li> 
    <li> <span __num="62" __label="true"> abnormal diastolic function </span> </li> 
   </ol> 
   <p> <span __num="63" __label="true"> There are some situations where symptoms alone may lead to a </span> <i> <span __num="64" __label="true"> mis </span> </i> <span __num="65" __label="true"> diagnosis. This is especially true in older patients who get short of breath mainly because they have very poor physical fitness. It can also happen with non-heart-related shortness of breath such as with lung disease. So diagnosing DHF requires some signs or symptoms of CHF like lung congestion, edema, raised jugular vein, etc. You do have to rule out problems like mitral valve disease and and lung disease. </span> <br> <span __num="66" __label="true"> DHF cannot usually be distinguished from </span> <a href="http://www.chfpatients.com/glossary_2.htm#shf" target="_blank"> <span __num="67" __label="true"> SHF </span> </a> <span __num="68" __label="true"> by patient history, physical exam, x-ray, and EKG alone. Diagnosis </span> <i> <span __num="69" __label="true"> requires </span> </i> <span __num="70" __label="true"> an estimate of LV size and </span> <a href="http://www.chfpatients.com/faq/ef.htm" target="_blank"> <span __num="71" __label="true"> EF </span> </a> <span __num="72" __label="true"> . These measurements can be made using </span> <a href="http://www.chfpatients.com/tests/tests.htm" target="_blank"> <span __num="73" __label="true"> echo, MUGA, or cath </span> </a> <span __num="74" __label="true"> . Really, DHF diagnosis is a matter of ruling out other possible causes in patients seeming to have heart failure but who have normal heart size and EF. </span> <br> <span __num="75" __label="true"> Since echo does have limits for spotting DHF and cath is invasive, one trial studied whether the BNP blood test could help spot diastolic heart failure. That study is shown on the </span> <a href="http://www.chfpatients.com/tests/bnp.htm" target="_blank"> <span __num="76" __label="true"> BNP Test page </span> </a> <span __num="77" __label="true"> . </span> <span class="h"> <span __num="78" __label="true"> It turns out that a quick BNP test can help a doctor diagnose DHF. </span> </span> </p> 
   <!--<div style="background:none #099; color:#fff; width:94%; margin-left:5%; font:xx-small Verdana,sans-serif; line-height:6px">&nbsp;</div>--> 
   <div class="center" style="margin:35px 0px 20px 0px"> 
    <table border="1" cellpadding="3" cellspacing="1" class="table2" frame="hsides" rules="all"> 
     <tbody> 
      <tr> 
       <td class="highlight" colspan="3" style="text-align:center"> <span __num="79" __label="true"> Diagnosis </span> <b> <span __num="80" __label="true"> : </span> </b> <span __num="81" __label="true"> Systolic versus diastolic heart failure </span> </td> 
      </tr> 
      <tr class="tr"> 
       <td> </td> 
       <td align="center"> <span __num="82"> Systolic Heart Failure - Reduced EF </span> <br> <span __num="83"> 30 patients </span> </td> 
       <td align="center"> <span __num="84"> Diastolic Heart Failure - Normal EF </span> <br> <span __num="85"> 20 patients </span> </td> 
      </tr> 
      <tr> 
       <td class="highlight" colspan="3"> <span __num="86" __label="true"> Symptoms </span> </td> 
      </tr> 
      <tr> 
       <td> <span __num="87" __label="true"> Shortness of breath on exertion </span> </td> 
       <td> <span __num="88" __label="true"> 85% </span> </td> 
       <td> <span __num="89" __label="true"> 96% </span> </td> 
      </tr> 
      <tr> 
       <td> <span __num="90" __label="true"> Waking at night short of breath </span> </td> 
       <td> <span __num="91" __label="true"> 55% </span> </td> 
       <td> <span __num="92" __label="true"> 50% </span> </td> 
      </tr> 
      <tr> 
       <td> <span __num="93" __label="true"> Difficulty breathing except upright </span> </td> 
       <td> <span __num="94" __label="true"> 60% </span> </td> 
       <td> <span __num="95" __label="true"> 73% </span> </td> 
      </tr> 
      <tr> 
       <td class="highlight" colspan="3"> <span __num="96" __label="true"> Physical Examination </span> </td> 
      </tr> 
      <tr> 
       <td> <span __num="97" __label="true"> Jugular vein swollen </span> </td> 
       <td> <span __num="98" __label="true"> 35% </span> </td> 
       <td> <span __num="99" __label="true"> 46% </span> </td> 
      </tr> 
      <tr> 
       <td> <span __num="100" __label="true"> Sounds in lungs </span> </td> 
       <td> <span __num="101" __label="true"> 72% </span> </td> 
       <td> <span __num="102" __label="true"> 70% </span> </td> 
      </tr> 
      <tr> 
       <td> <a href="http://www.fpnotebook.com/CV72.htm" target="_blank"> <span __num="103" __label="true"> Point of maximum impulse </span> </a> </td> 
       <td> <span __num="104" __label="true"> 50% </span> </td> 
       <td> <span __num="105" __label="true"> 60% </span> </td> 
      </tr> 
      <tr> 
       <td> <a href="s3s4.htm" target="_blank"> <span __num="106"> S3 </span> </a> </td> 
       <td> <span __num="107"> 45% </span> </td> 
       <td> <span __num="108"> 65% </span> </td> 
      </tr> 
      <tr> 
       <td> <a href="s3s4.htm" target="_blank"> <span __num="109"> S4 </span> </a> </td> 
       <td> <span __num="110"> 45% </span> </td> 
       <td> <span __num="111"> 66% </span> </td> 
      </tr> 
      <tr> 
       <td> <span __num="112" __label="true"> Enlarged (congested) liver </span> </td> 
       <td> <span __num="113" __label="true"> 15% </span> </td> 
       <td> <span __num="114" __label="true"> 16% </span> </td> 
      </tr> 
      <tr> 
       <td> <a href="edema.htm" target="_blank"> <span __num="115" __label="true"> Edema </span> </a> </td> 
       <td> <span __num="116" __label="true"> 30% </span> </td> 
       <td> <span __num="117" __label="true"> 40% </span> </td> 
      </tr> 
      <tr> 
       <td> <span __num="118" __label="true"> Heart enlargement on chest x-ray </span> </td> 
       <td> <span __num="119" __label="true"> 90% </span> </td> 
       <td> <span __num="120" __label="true"> 96% </span> </td> 
      </tr> 
      <tr> 
       <td> <span __num="121" __label="true"> High pulmonary (lung) pressures </span> </td> 
       <td> <span __num="122" __label="true"> 75% </span> </td> 
       <td> <span __num="123" __label="true"> 80% </span> </td> 
      </tr> 
     </tbody> 
    </table> 
   </div> 
   <h4> <span __num="124" __label="true"> How common is DHF? </span> <a name="prevalence"> </a> </h4> 
   <p> <span __num="125" __label="true"> As many as 33% of patients with obvious heart failure and a normal EF may have DHF. Risk of DHF increases with age </span> <b> <span __num="126" __label="true"> : </span> </b> </p> 
   <ol> 
    <li> <span __num="127" __label="true"> 15% in patients under 60 years </span> </li> 
    <li> <span __num="128" __label="true"> 35% in patients 60 to 70 years </span> </li> 
    <li> <span __num="129" __label="true"> 50% in patients over 70 years old </span> </li> 
   </ol> 
   <h5> <span __num="130" __label="true"> Mortality </span> <a name="mortality"> </a> </h5> 
   <p> <span class="h"> <span __num="131" __label="true"> Prognosis of patients with DHF is better than for SHF. </span> </span> <span __num="132" __label="true"> Annual mortality for DHF is about 5 to 8%, while it is about 10 to 15% for SHF. In healthy people of the same age, mortality is about 1%. In DHF patients, prognosis is also affected by cause. When CAD is </span> <i> <span __num="133" __label="true"> not </span> </i> <span __num="134" __label="true"> the cause, annual mortality is much better, at about 2% to 3%. Age also affects risk of death. The 5-year mortality rate in DHF patients is </span> <b> <span __num="135" __label="true"> : </span> </b> </p> 
   <ol> 
    <li> <span __num="136" __label="true"> 25% in patients under 60 years old </span> </li> 
    <li> <span __num="137" __label="true"> 35% in patients 60 to 70 years </span> </li> 
    <li> <span __num="138" __label="true"> 50% in patients over 70 years old </span> </li> 
   </ol> 
   <h6> <span __num="139" __label="true"> Complications </span> <a name="complications"> </a> </h6> 
   <p> <span __num="140" __label="true"> The complication rate is about the same as for SHF patients. DHF causes frequent outpatient visits and hospital admissions. The one year readmission rate is almost 50% in DHF patients. </span> </p> 
   <div style="background:transparent; color:#f00; font:italic bold medium Verdana,Arial,sans-serif; letter-spacing:.07em"> 
    <span __num="141" __label="true"> Treatment </span> 
    <a name="treatment"> </a> 
   </div> 
   <p> <a href="guidelines_99.htm" target="_blank"> <span __num="142" __label="true"> Treatment guidelines </span> </a> <span __num="143" __label="true"> for systolic heart failure are based on large, properly done trials. Unfortunately, no such trials exist for DHF. So guidelines come from small trials, a doctor's experience, and his understanding of the disease. The </span> <i> <span __num="144" __label="true"> general </span> </i> <span __num="145" __label="true"> approach to treating DHF has 3 main steps </span> <b> <span __num="146" __label="true"> : </span> </b> </p> 
   <ol> 
    <li> <span __num="147" __label="true"> Treatment should reduce symptoms, mainly by lowering </span> <a href="http://www.chfpatients.com/glossary_2.htm#pulmonary" target="_blank"> <span __num="148" __label="true"> pulmonary </span> </a> <span __num="149" __label="true"> pressure. Ways to reduce pressure include reducing heart size, maintaining good pumping in the heart's upper chambers, and slowing the heart rate. </span> </li> 
    <li> <span __num="150" __label="true"> Treatment should target the underlying cause if possible. For example, high blood pressure should be controlled, </span> <a href="http://www.chfpatients.com/glossary_2.htm#remodeling" target="_blank"> <span __num="151" __label="true"> remodeling </span> </a> <span __num="152" __label="true"> should be reversed, the aortic valve replaced if necessary, and ischemia treated by increasing blood flow to the heart and reducing its need for oxygen </span> </li> 
    <li> <span __num="153" __label="true"> Treatment should target the bodily systems changed by the disease, mainly </span> <a href="http://www.chfpatients.com/glossary_2.htm#neurohormones" target="_blank"> <span __num="154" __label="true"> neurohormonal </span> </a> <span __num="155" __label="true"> systems </span> </li> 
   </ol> 
   <div class="subheading"> 
    <span __num="156" __label="true"> Drug Therapy - General Principles </span> 
    <a name="drug_general"> </a> 
   </div> 
   <p> <span class="h"> <span __num="157" __label="true"> With some exceptions, many of the drugs used to treat systolic heart pressure are also used to treat diastolic heart failure. However, the reason they are used and the dose may be different for DHF </span> </span> <span __num="158" __label="true"> . </span> <br> <span __num="159" __label="true"> For example, in DHF beta-blockers are used to make filling the heart with blood take longer, and to change the heart's response to exercise. In SHF, beta-blockers are used to increase pumping power and reverse heart remodeling. Diuretic dose for DHF is usually much smaller than for SHF. Calcium channel blockers have no place in SHF treatment but may help DHF. </span> <br> <span __num="160" __label="true"> The first step in treating DHF patients is to reduce lung congestion. You do that by lowering pulmonary (lung) pressure. This has 3 steps </span> <b> <span __num="161" __label="true"> : </span> </b> </p> 
   <dl> 
    <dt class="arial"> 
     <span __num="162" __label="true"> Reduce heart size </span> 
    </dt> 
    <dd> 
     <span __num="163" __label="true"> At first, heart size </span> 
     <!--LV volume--> 
     <span __num="164" __label="true"> can be reduced by restricting fluid and sodium intake, by dialysis or filtering the blood, </span> 
     <a href="http://www.chfpatients.com/glossary_2.htm#plasmapheresis" target="_blank"> <span __num="165" __label="true"> plasmapheresis </span> </a> 
     <span __num="166" __label="true"> , and diuretics. Relaxing (dilating) the blood vessels using nitro or morphine is effective but should be started at low doses to avoid low blood pressure. Low blood pressure can be a real problem in DHF patients. </span> 
     <i> <span __num="167" __label="true"> Long-term </span> </i> 
     <span __num="168" __label="true"> treatment should include small to moderate diuretic doses, mild doses of long-acting nitro, and </span> 
     <a href="http://www.chfpatients.com/rec/recipes.htm" target="_blank"> <span __num="169" __label="true"> restricted sodium intake </span> </a> 
     <span __num="170" __label="true"> . </span> 
     <a href="http://www.chfpatients.com/meds.htm#aldactone2" target="blank"> <span __num="171" __label="true"> Aldactone </span> </a> 
     <span __num="172" __label="true"> (spironolactone) may be effective long-term because it suppresses the </span> 
     <a href="http://www.chfpatients.com/glossary_2.htm#ras" target="_blank"> <span __num="173" __label="true"> RAS </span> </a> 
     <span __num="174" __label="true"> . ACE inhibitors and </span> 
     <a href="http://www.chfpatients.com/glossary.htm#arb" target="_blank"> <span __num="175" __label="true"> ARBs </span> </a> 
     <span __num="176" __label="true"> reduce fluid retention and oxygen demand. </span> 
     <br> 
    </dd> 
    <dt class="arial"> 
     <span __num="177" __label="true"> Make the heart's chambers beat together as a team </span> 
    </dt> 
    <dd> 
     <span __num="178" __label="true"> The second step in lowering pulmonary pressure is to keep the heart's upper chambers (atriums) beating properly. </span> 
     <!--This reduces LV diastolic pressure--> 
     <span class="h"> <span __num="179" __label="true"> Atrial fibrillation is poorly tolerated in DHF patients because it increases diastolic pressures, causing lung congestion and low blood pressure.In patients with a-fib, restoring normal rhythm should be a priority. </span> </span> 
     <span __num="180" __label="true"> Patients who need a </span> 
     <a href="http://www.chfpatients.com/implants/implants.htm" target="_blank"> <span __num="181" __label="true"> pacemaker </span> </a> 
     <span __num="182" __label="true"> should have atrial pacing as well as ventricular pacing. </span> 
     <br> 
    </dd> 
    <dt class="arial"> 
     <span __num="183" __label="true"> Slowing the heart rate </span> 
    </dt> 
    <dd> 
     <span __num="184" __label="true"> The third step in lowering pulmonary pressures is to slow the heart rate. This gives the heart more time to relax so it can fill with blood. </span> 
     <span class="h"> <span __num="185" __label="true"> Fast heart rate is poorly tolerated in DHF patients </span> </span> 
     <span __num="186" __label="true"> because rapid heart rate </span> 
     <b> <span __num="187" __label="true"> : </span> </b> 
     <ol style="margin:4px 3% 0px 5%"> 
      <li> <span __num="188" __label="true"> increases the heart's oxygen demand and reduces blood flow to the heart, causing </span> <a href="http://www.chfpatients.com/glossary_2.htm#ischemia" target="_blank"> <span __num="189" __label="true"> ischemia </span> </a> <span __num="190" __label="true"> even without </span> <a href="http://www.chfpatients.com/glossary.htm#cad" target="_blank"> <span __num="191" __label="true"> CAD </span> </a> </li> 
      <li> <span __num="192" __label="true"> prevents full relaxation of the heart muscle, which raises pressure and reduces the heart's flexibility </span> </li> 
      <li> <span __num="193" __label="true"> shortens the heart's relaxation period, making it incomplete, which reduces the amount of blood pumped per beat </span> </li> 
     </ol> 
    </dd> 
   </dl> 
   <p style="margin-top:7px"> <span __num="194" __label="true"> For these reasons, most doctors use beta-blockers and calcium channel blockers to slow the heart rate a </span> <i> <span __num="195" __label="true"> lot </span> </i> <span __num="196" __label="true"> in DHF patients. However, slowing the heart rate too much can reduce cardiac output despite better filling. </span> <span class="h"> <span __num="197" __label="true"> This is why DHF patients need very individualized treatment. </span> </span> <span __num="198" __label="true"> An initial goal might be a resting heart rate of about 60 beats per minute. </span> <br> <span __num="199" __label="true"> Beta-blockers and calcium channel blockers increase the time it takes the heart to fill with blood. This helps keep pulmonary pressures low. However, these drugs also directly </span> <i> <span __num="200" __label="true"> reduce </span> </i> <span __num="201" __label="true"> the heart's ability to relax by their effects at the cell level. It's a tricky balance to strike in DHF patients. The overall effect of these drugs in DHF patients is improved symptoms. </span> <br> <span class="h"> <span __num="202" __label="true"> The long-term effect of calcium channel blockers on diastolic heart failure patients is unknown. All calcium channel blockers except </span> </span> <a href="http://www.chfpatients.com/meds.htm#amlodipine2" target="_blank"> <span class="h" style="font-weight:bold"> <span __num="203" __label="true"> amlodipine </span> </span> </a> <span class="h"> <i> <span __num="204" __label="true"> increase </span> </i> <span __num="205" __label="true"> mortality in patients with </span> <i> <span __num="206" __label="true"> systolic </span> </i> <span __num="207" __label="true"> heart failure. </span> </span> </p> 
   <div class="subheading"> 
    <a name="nebivolol_for_seniors_with_good_EF"> </a> 
    <span __num="208" __label="true"> Nebivolol Helps CHF Seniors with Normal EF </span> 
   </div> 
   <p> <i> <span __num="209" __label="true"> March 27, 2006 </span> </i> <span __num="210" __label="true"> - A "third generation" (new) beta-blocker called Nebivolol is on the way. </span> <span class="h"> <span __num="211" __label="true"> Nebivolol has the main good benefit of Toprol-XL (beta-1 blocking without beta-2 blocking) plus one of the good benefits of Coreg (relaxing the arteries, called vasodilation). It also helps </span> </span> <a href="http://www.chfpatients.com/glossary.htm#endothelium" target="_blank"> <span class="h"> <span __num="212" __label="true"> endothelial </span> </span> </a> <span class="h"> <span __num="213" __label="true"> function and is a powerful anti-oxidant. Nebivolol does this without all of Coreg's side effects. </span> </span> <br> <span __num="214" __label="true"> Researchers studied how nebivolol affects systolic versus diastolic left heart function in patients. This substudy included 104 patients </span> <b> <span __num="215" __label="true"> ; </span> </b> <span __num="216" __label="true"> 43 had an EF less than 36%. Echo was done on each patient to take quite a few heart measures </span> 
    <!--LV end-systolic volume (ESV), EF, mitral valve E/A ratio, and E-wave deceleration time--> <span __num="217" __label="true"> at study start and again one year later. </span> 
    <!--Echocardiograms were submitted to a core laboratory to perform quantitative analysis in blinded condition.--> <br> <span __num="218" __label="true"> In the group with EF less than 36%, nebivolol reduced heart size </span> 
    <!--ESV (adjusted difference between treatments 25.8 mL, 95%CI: -46.6; -5.0, P=0.016)--> <span __num="219" __label="true"> and improved EF 5% </span> 
    <!--adjusted difference between treatments 4.6%, 95%CI: 1.3;7.9, P=0.008--> <span __num="220" __label="true"> . Other measures remained the same. In patients with EF higher than 36%, no changes in the heart muscle were seen. </span> <br> <span class="h"> <span __num="221" __label="true"> So in patients with weakly pumping hearts (low EF), nebivolol reduces heart size and improves EF. In patients with near-normal or normal EF (diastolic heart failure) no changes in the heart muscle were seen. None the less, risk of death or heart-related hospitalization improved in both groups in SENIORS. </span> </span> <br> <span __num="222" __label="true"> The SENIORS trial showed that nebivolol reduces risk of death and heart-related hospitalizations in senior CHFers </span> <b> <span __num="223" __label="true"> regardless of EF </span> </b> <span __num="224" __label="true"> . What does this mean? It suggests that </span> <a href="http://www.chfpatients.com/glossary.htm#chfer" target="_blank"> <span __num="225" __label="true"> CHFers </span> </a> <span __num="226" __label="true"> with </span> <a href="http://www.chfpatients.com/faq/dhf.htm" target="_blank"> <span __num="227" __label="true"> diastolic heart failure </span> </a> <span __num="228" __label="true"> may now have a drug proven to help them. </span> <br> <i> <span __num="229" __label="true"> Jon's note </span> </i> <span __num="230" __label="true"> : The average age in the SENIORS trial was 76 years. </span> <br> <br> <span __num="231" __label="true"> Source: Eur Heart J. 2006 Mar;27(5):562-8. Epub 2006 Jan 27. </span> <br> <span __num="232" __label="true"> Title: Effects of nebivolol in elderly heart failure patients with or without systolic left ventricular dysfunction: results of the SENIORS echocardiographic substudy. </span> <br> <span __num="233" __label="true"> Authors: Ghio S , Magrini G , Serio A, Klersy C, Fucilli A, Ronaszeki A, Karpati P, Mordenti G, Capriati A, Poole-Wilson PA, Tavazzi L; SENIORS investigators. </span> 
    <!--s.ghio@smatteo.pv.it--> <span __num="234" __label="true"> PMID: 16443607 </span> </p> 
   <div class="subheading"> 
    <span __num="235" __label="true"> Drugs and Exercise Tolerance </span> 
    <a name="exercise"> </a> 
   </div> 
   <p> <span __num="236" __label="true"> Exercise in a healthy person makes the heart relax more quickly and lowers LV pressure faster. The heart muscle actually stretches and gets larger when full of blood just before pumping it out. This increases </span> <a href="http://www.chfpatients.com/faq/ef.htm" target="_blank"> <span __num="237" __label="true"> EF </span> </a> 
    <!--Frank Starling mechanism--> <span __num="238" __label="true"> . In a healthy person, these actions help the body handle exercise. </span> <br> <span __num="239" __label="true"> In DHF, those actions are very limited. The heart's stiffness prevents it from stretching to increase its size when filled with blood. EF does not rise, and patients get short of breath and very tired. Often, there is quite a rise in blood pressure and heart rate during exercise. The rise in blood pressure makes the heart work harder, which screws up the entire pumping cycle. </span> <br> <span __num="240" __label="true"> These changes increase diastolic pressures. High diastolic pressures reduce lung function and make breathing harder. Low heart output during exercise causes fatigue in the legs and other muscles. </span> <br> <span class="h"> <span __num="241" __label="true"> Small trials show that calcium channel blockers, beta-blockers, and </span> </span> <a href="http://www.chfpatients.com/ace.htm#arb" target="_blank"> <span class="h"> <span __num="242" __label="true"> ARBs </span> </span> </a> <span class="h"> <span __num="243" __label="true"> improve exercise ability in many DHF patients. However, these drugs do not always improve heart function </span> 
     <!--or increase the heart's relaxation--> <span __num="244" __label="true"> . </span> </span> </p> 
   <div class="subheading"> 
    <span __num="245" __label="true"> Inotropes </span> 
    <a name="inotropes"> </a> 
   </div> 
   <p> <span __num="246" __label="true"> Use </span> <a href="http://www.chfpatients.com/inotropes.htm" target="_blank"> <span __num="247" __label="true"> inotropic drugs </span> </a> <span __num="248" __label="true"> with caution. Since ejection fraction is often okay in DHF patients, inotropes may give no benefit at all. However, such drugs can cause harm in these patients. Inotropic drugs may help in the short-term for lung congestion </span> 
    <!--improve sarcoplasmic reticulum function--> <span __num="249" __label="true"> but even short-term use may cause </span> <a href="http://www.chfpatients.com/glossary_2.htm#ischemia" target="_blank"> <span __num="250" __label="true"> ischemia </span> </a> <span __num="251" __label="true"> , speed up heart rate, or trigger arrhythmias. </span> </p> 
   <div class="subheading"> 
    <span __num="252" __label="true"> Digoxin (Lanoxin, digitalis) </span> 
    <a name="digoxin"> </a> 
   </div> 
   <p> <a href="http://www.chfpatients.com/meds_old.htm#digoxin" target="blank"> <span __num="253" __label="true"> Digoxin </span> </a> <span __num="254" __label="true"> (Lanoxin) </span> 
    <!--inhibits the sodium-potassium-ATPase pump, increases cellular calcium and thereby--> <span __num="255" __label="true"> strengthens the heart's pumping power. This increases </span> 
    <!--systolic--> <span __num="256" __label="true"> energy demand </span> 
    <!--while adding to calcium overload in diastole--> <span __num="257" __label="true"> , which may only show up during stress like exercise or ischemia, when digoxin can worsen diastolic function. </span> <span class="h"> <span __num="258" __label="true"> With the exception of patients in chronic atrial fibrillation (to slow ventricular rate), digoxin is not recommended for DHF. </span> </span> </p> 
   <div class="subheading"> 
    <span __num="259" __label="true"> Coronary Artery Disease </span> 
    <a name="cad"> </a> 
   </div> 
   <p> <span __num="260" __label="true"> In </span> <a href="http://www.chfpatients.com/glossary.htm#cad" target="_blank"> <span __num="261" __label="true"> CAD </span> </a> <span __num="262" __label="true"> , treatment should aim to reduce the heart's oxygen demand and increase blood flow to the heart. Drugs like nitrates (nitroglycerine), calcium channel blockers, and beta-blockers have all been shown to help. Clearing blocked arteries with angioplasty or </span> <a href="http://www.chfpatients.com/glossary.htm#cabg" target="_blank"> <span __num="263" __label="true"> CABG </span> </a> <span __num="264" __label="true"> may also help diastolic heart failure patients with CAD. </span> </p> 
   <div class="center" style="margin:20px 9% 20px 6%"> 
    <table border="1" cellpadding="3" cellspacing="1" class="table" frame="hsides" rules="all"> 
     <tbody> 
      <tr> 
       <td class="highlight" colspan="2" style="text-align:center; font-family:Verdana,Arial,sans-serif"> <span __num="265" __label="true"> Drug treatment of diastolic heart failure </span> </td> 
      </tr> 
      <tr> 
       <td> <span __num="266" __label="true"> Loop diuretics </span> </td> 
       <td> <span __num="267" __label="true"> Bumex (bumetanide), Lasix (furosemide), Demadex (torsemide) </span> </td> 
      </tr> 
      <tr> 
       <td> <span __num="268" __label="true"> Thiazide diuretics </span> </td> 
       <td> <span __num="269" __label="true"> Hygroton (chlorthalidone), Hydrodiuril, Esidrix (HCTZ, hydrochlorothiazide), Amiloride, </span> <a href="http://www.chfpatients.com/meds.htm#aldactone2" target="blank"> <span __num="270" __label="true"> Aldactone </span> </a> <span __num="271" __label="true"> (spironolactone) </span> </td> 
      </tr> 
      <tr> 
       <td> <span __num="272" __label="true"> Long-acting nitrates </span> </td> 
       <td> <span __num="273" __label="true"> Isordil, Sorbitrate (Isosorbide Dinitrate), Imdur (Isosorbide mononitrate) </span> </td> 
      </tr> 
      <tr> 
       <td> <span __num="274" __label="true"> Beta-blockers </span> </td> 
       <td> <span __num="275" __label="true"> See </span> <a href="http://www.chfpatients.com/beta_overview.htm" target="_blank"> <span __num="276" __label="true"> this page </span> </a> </td> 
      </tr> 
      <tr> 
       <td> <span __num="277" __label="true"> Calcium channel blockers </span> </td> 
       <td> <span __num="278" __label="true"> Norvasc (amlodipine), Cardizem (diltiazem), Isoptin (verapamil), Procardia (nifedipine) </span> </td> 
      </tr> 
      <tr> 
       <td> <a href="http://www.chfpatients.com/glossary_2.htm#ras" target="_blank"> <span __num="279" __label="true"> RAS </span> </a> <span __num="280" __label="true"> inhibitors </span> </td> 
       <td> <span __num="281" __label="true"> ACE inhibitors (see </span> <a href="http://www.chfpatients.com/ace.htm" target="_blank"> <span __num="282" __label="true"> this page </span> </a> <span __num="283" __label="true"> ), ARBs (see </span> <a href="http://www.chfpatients.com/ace.htm#arb" target="_blank"> <span __num="284" __label="true"> this page </span> </a> <span __num="285" __label="true"> ), and aldosterone antagonists </span> </td> 
      </tr> 
     </tbody> 
    </table> 
   </div> 
   <div class="heading"> 
    <span __num="286" __label="true"> Questions and Answers </span> 
    <a name="q_and_a"> </a> 
   </div> 
   <dl> 
    <dt> 
     <span __num="287" __label="true"> Question </span> 
    </dt> 
    <dd> 
     <span __num="288" __label="true"> Is the rise in DHF cases caused by doctors better recognizing the condition or has there been an actual increase in the number of cases? </span> 
    </dd> 
    <dt> 
     <span __num="289" __label="true"> Dr. Zile </span> 
    </dt> 
    <dd> 
     <span __num="290" __label="true"> I think it is both. We are recognizing it better. Also, the general population is aging so high blood pressure, heart disease, and diabetes are rising just because they are more common in the elderly. Age itself causes changes in the heart that encourage DHF </span> 
     <br> 
     <br> 
    </dd> 
    <dt> 
     <span __num="291" __label="true"> Question </span> 
    </dt> 
    <dd> 
     <span __num="292" __label="true"> Why the controversy surrounding the diagnosis of DHF? </span> 
    </dd> 
    <dt> 
     <span __num="293" __label="true"> Dr. Zile </span> 
    </dt> 
    <dd> 
     <span __num="294" __label="true"> The guidelines that exist or have been proposed come from the European Cardiology Society and the Canadian Heart Society, as well as from a recent editorial by Vasan and Levy published in the journal Circulation. They all require that 3 standards be met to diagnose DHF </span> 
     <b> <span __num="295" __label="true"> : </span> </b> 
     <br> 
     <br> 
     <b> <span __num="296"> 1) </span> </b> 
     <span __num="297" __label="true"> signs and symptoms of heart failure </span> 
     <br> 
     <b> <span __num="298"> 2) </span> </b> 
     <span __num="299" __label="true"> normal EF </span> 
     <br> 
     <b> <span __num="300"> 3) </span> </b> 
     <span __num="301" __label="true"> problems with diastolic function seen by </span> 
     <a href="http://www.chfpatients.com/tests/tests.htm" target="_blank"> <span __num="302" __label="true"> cath or echo </span> </a> 
     <br> 
     <br> 
     <span __num="303" __label="true"> I think these criteria are too tight and that number 3 should be eliminated. Ninety percent of patients who fit the first 2 will indeed turn out to have diastolic heart failure confirmed by cath. The problem arises because measuring diastolic function with noninvasive tests like echo is difficult and confusing. </span> 
     <!--The most common noninvasive measure of diastolic function is inflow velocity through the mitral valve using a Doppler technique measuring the E velocity and the A velocity--> 
     <br> 
     <span __num="304" __label="true"> Why? Echo usually measures what we call the E and A velocities. However, E-wave velocity drops with age, heart enlargement, and DHF. So in someone with congested lungs and signs of high heart pressures </span> 
     <!--such as high PCWP and high LV diastolic pressure--> 
     <span __num="305" __label="true"> those E-waves can appear normal. While the E-wave should be low in DHF patients, it may appear normal if the doctor is not experienced at treating diastolic heart failure. </span> 
     <br> 
     <br> 
    </dd> 
    <dt> 
     <span __num="306" __label="true"> Question </span> 
    </dt> 
    <dd> 
     <span __num="307" __label="true"> Is finding diastolic problems on an echo that is done for another reason important, even in a patient with no history or symptoms of </span> 
     <a href="http://www.chfpatients.com/CHF.htm" target="_blank"> <span __num="308" __label="true"> CHF </span> </a> 
     <span __num="309" __label="true"> ? </span> 
    </dd> 
    <dt> 
     <span __num="310" __label="true"> Dr. Zile </span> 
    </dt> 
    <dd> 
     <span __num="311" __label="true"> Yes. In systolic heart failure, a wide range of patient types is seen - from those with low EFs but no symptoms, to those with mild or moderate symptoms, to </span> 
     <a href="http://www.chfpatients.com/CHFinfo.htm#classes" target="_blank"> <span __num="312" __label="true"> class 4 </span> </a> 
     <span __num="313" __label="true"> patients with severe symptoms even at rest. The same range is likely to be seen in diastolic heart failure patients </span> 
     <br> 
     <br> 
    </dd> 
    <dt> 
     <span __num="314" __label="true"> Question </span> 
    </dt> 
    <dd> 
     <span __num="315" __label="true"> Since most of the blood that fills the LV does so in the early part of the filling phase, why does it help to lengthen that phase in DHF patients by slowing heart rate? Doesn't increasing heart rate increase cardiac output? </span> 
    </dd> 
    <dt> 
     <span __num="316" __label="true"> Dr. Zile </span> 
    </dt> 
    <dd> 
     <span __num="317" __label="true"> While speeding up heart rate increases output, it also raises pressure </span> 
     <!--PCWP--> 
     <span __num="318" __label="true"> , making symptoms worse. In a healthy person, raising heart rate does not change pressures </span> 
     <!--end-diastolic pressure--> 
     <span __num="319" __label="true"> much because the ventricle is able to relax faster as heart rate speeds up. </span> 
     <br> 
     <span __num="320" __label="true"> However, in DHF patients, the response to increased heart rate is not normal. When heart rate speeds up, the ventricle cannot relax any faster. This raises pressures </span> 
     <!--PCWP--> 
     <span __num="321" __label="true"> . By slowing heart rate, you give the ventricle more time to relax, lowering filling pressures. Also, many DHF patients have ischemia. By slowing the heart rate, you reduce the heart's need for oxygen and that helps balance supply and demand of blood and oxygen </span> 
     <br> 
     <br> 
    </dd> 
    <dt> 
     <span __num="322" __label="true"> Question </span> 
    </dt> 
    <dd> 
     <span __num="323" __label="true"> Seeing that pretty much the same drugs are used to treat both diastolic are systolic heart failure, how important is it to tell DHF from SHF? </span> 
    </dd> 
    <dt> 
     <span __num="324" __label="true"> Dr. Zile </span> 
    </dt> 
    <dd> 
     <span __num="325" __label="true"> There are at least 40 well-done trials to guide treatment for systolic heart failure patients. This is not true for DHF, so its treatment is less certain. </span> 
     <span class="h"> <span __num="326" __label="true"> Even though we say ACE inhibitors will probably help and ARBs may help, and beta-blockers may help, and so on, it is not proven in large numbers of DHF patients. </span> </span> 
     <span __num="327" __label="true"> Also, there are differences in the way you use those drugs and in the doses you use. </span> 
     <br> 
     <span __num="328" __label="true"> The best example is beta-blockers. Treating heart failure in patients with an EF of 30% requires that beta-blocker dose be raised carefully, starting with tiny doses and raising it slowly over several months. In the DHF patient, that very slow rise in dose is not usually necessary. </span> 
     <br> 
     <span __num="329" __label="true"> Another example is calcium channel blockers. These drugs should not be used in systolic heart failure patients at all, but they may help DHF patients. As another example, diuretic use needs to be much more cautious in the DHF patient since drying them out too much can easily cause too-low blood pressure. </span> 
     <br> 
     <span __num="330" __label="true"> So even though the same drugs may be used to treat SHF and DHF, there are important differences. It is important for doctors to be aware of the differences when treating CHF patients </span> 
     <br> 
     <br> 
    </dd> 
    <dt> 
     <span __num="331" __label="true"> Question </span> 
    </dt> 
    <dd> 
     <span __num="332" __label="true"> Have beta-blockers and calcium channel blockers been shown to reverse measurements of diastolic dysfunction? </span> 
    </dd> 
    <dt> 
     <span __num="333" __label="true"> Dr. Zile </span> 
    </dt> 
    <dd> 
     <span class="h"> <span __num="334" __label="true"> If you give beta-blockers to DHF patients, their relaxation rate gets worse instead of better. Despite this, patients feel better - </span> </span> 
     <span class="highlight"> <span __num="335" __label="true"> so measurements don't always agree with how patients actually do while taking a drug. </span> </span> 
     <span class="h"> <span __num="336" __label="true"> With calcium channel blockers, DHF patients feel better while taking them </span> <i> <span __num="337" __label="true"> and </span> </i> <span __num="338" __label="true"> their filling rates usually get better. There is a complex relationship between how any one drug affects a person versus how that drug affects the measurements we take of that person's heart function. </span> </span> 
     <br> 
     <span __num="339" __label="true"> One study that used a calcium channel blocker and another study using an ARB showed improved exercise times in patients taking these drugs. However, neither study showed improved measurements of heart relaxation or stiffness. I don't think you can rely just on measures of heart function to guide treatment. </span> 
     <br> 
     <br> 
    </dd> 
    <dt> 
     <span __num="340" __label="true"> Question </span> 
    </dt> 
    <dd> 
     <span __num="341" __label="true"> In making a DHF diagnosis, what must be ruled out besides systolic heart failure? </span> 
    </dd> 
    <dt> 
     <span __num="342" __label="true"> Dr. Zile </span> 
    </dt> 
    <dd> 
     <span __num="343" __label="true"> Besides excluding SHF, it is also important to rule out mitral valve stenosis and chronic lung disease, both of which can imitate heart failure with a normal EF </span> 
     <br> 
     <br> 
    </dd> 
    <dt> 
     <span __num="344" __label="true"> Question </span> 
    </dt> 
    <dd> 
     <span __num="345" __label="true"> What blood pressure drugs are most likely to help heart enlargement in DHF patients? </span> 
    </dd> 
    <dt> 
     <span __num="346" __label="true"> Dr. Zile </span> 
    </dt> 
    <dd> 
     <span __num="347" __label="true"> Although it hasn't been clearly proven yet, I think drugs that alter the neurohormonal systems work well. They not only lower pressure, but they also reduce the effects of overactive bodily systems. The problem is that in most trials, heart enlargement only goes down about 10 to 15%. This will probably improve heart function but not totally reverse DHF. If those high blood pressure trials had been longer by 5 or 10 years, we might have seen more improvement proven down the road. </span> 
     <br> 
     <span __num="348" __label="true"> What evidence do I have to support that? The answer comes from patients with aortic stenosis who had their aortic valves replaced. Three to 5 years after aortic valve replacement, ventricular size and stiffness often returned to normal, improving the heart's stiffness and relaxation </span> 
     <a name="source"> </a> 
    </dd> 
   </dl> 
   <p> <span __num="349" __label="true"> Title: Diastolic Heart Failure: Diagnosis and Treatment </span> <br> <span __num="350" __label="true"> Authors: Dr. Michael R. Zile, Dr. Janet M. Simsic </span> <br> <span __num="351" __label="true"> Source: Clinical Cornerstone 3(2):13-24, 2000 </span> </p> 
   <p class="smallcounter"> <span __num="352"> All information on this site is opinion only. All concepts, explanations, trials, and studies have been re-written in plain English and may contain errors. I am not a doctor. Use the reference information at the end of each article to search </span> <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi" target="_blank"> <span __num="353"> MedLine </span> </a> <span __num="354"> for more complete and accurate information. All original copyrights apply. No information on this page should be used by any person to affect their medical, legal, educational, social, or psychological treatment in any way. I am not a doctor. This web site and all its pages, graphics, and content copyright © 1997, 1998, 1999, 2000, 2001, 2002, 2003, 2004, 2005, 2006 Jon C. </span> </p> 
   <div class="center" style="padding-top:30px"> 
    <table border="0" cellpadding="0" cellspacing="0" width="96%"> 
     <tbody> 
      <tr> 
       <td align="center" class="counter" valign="bottom"> <a href="http://www.chfpatients.com/contact.htm"> <span __num="355"> Talk to Jon </span> </a> </td> 
       <td align="center" class="counter" valign="bottom"> <a href="http://www.chfpatients.com/index.html"> <span __num="356"> Site Index </span> </a> </td> 
      </tr> 
     </tbody> 
    </table> 
   </div> 
   <br> 
   <br> 
  </text> 
 </body>
</html>